Template:Streptococcal Pharyngitis Antibiotics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
*[[Penicillin V]] 250mg PO BID x 10d (child) or 500mg BID x 10d (adolescent or adult) | *[[Penicillin V]] 250mg PO BID x 10d (child) or 500mg BID x 10d (adolescent or adult) | ||
*[[Bicillin L-A]] <27 kg: 0.6 million units; ≥27 kg: 1.2 million units IM x 1 | *[[Bicillin L-A]] <27 kg: 0.6 million units; ≥27 kg: 1.2 million units IM x 1 | ||
*[[Amoxicillin]] 500-875 mg PO q12h or 250-500 PO q8h for 10d<ref>Shah, U. K., MD. (2020, October 14). Tonsillitis and Pharyngitis Organism-Specific Therapy: Specific Organisms and Therapeutic Regimens. Emedicine. https://emedicine.medscape.com/article/2011872-overview</ref> | |||
'''[[Penicillin]] allergic (mild):<ref name=Shulman12>Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82</ref>''' | '''[[Penicillin]] allergic (mild):<ref name=Shulman12>Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82</ref>''' | ||
Revision as of 18:28, 26 July 2021
Treatment can be delayed for up to 9 days and still prevent major sequelae
Penicillin Options:[1]
- Penicillin V 250mg PO BID x 10d (child) or 500mg BID x 10d (adolescent or adult)
- Bicillin L-A <27 kg: 0.6 million units; ≥27 kg: 1.2 million units IM x 1
- Amoxicillin 500-875 mg PO q12h or 250-500 PO q8h for 10d[2]
Penicillin allergic (mild):[1]
- Cefuroxime 10mg/kg PO QID x 10d (child) or 250mg PO BID x 4d
Penicillin allergic (anaphylaxis):[1]
- Clindamycin 7.5mg/kg PO QID x 10d (child) or 450mg PO TID x 10d OR
- Azithromycin 12mg/kg QD (child) or 500mg on day 1; then 250mg on days 2-5
- ↑ 1.0 1.1 1.2 Shulman, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2012;55(10):1279–82
- ↑ Shah, U. K., MD. (2020, October 14). Tonsillitis and Pharyngitis Organism-Specific Therapy: Specific Organisms and Therapeutic Regimens. Emedicine. https://emedicine.medscape.com/article/2011872-overview